AzTrials
AzTrials

Cardiac ArrestAfterROSC1NCT04167891

Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Out of Hospital Cardiac Arrest

An observational study of Cardiac Arrest, run by AfterROSC at 27 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Arrest
What is being tested?
Calculation of early prognosis score
How many people
1,144 participants
Where
27 sitesin 2 countries
Study dates
1 Aug 2020to 1 Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This is an observational, prospective, multicentric prognostic study. The study period is 1 year, and we plan to include 597 patients in 21 ICUs in France. For all patients included, medical history, clinical data, paraclinical results and outcome (at hospital discharge and at 3 months, including modified Rankin score) will be prospectively collected by local investigator, according to an electronical CRF.

Who may be able to join

  • All adult patients, major, admitted to intensive care after out-of-hospital cardiac arrest and comatose (defined by Glasgow score ≤ 8) on admission.

Who cannot join

  • cardiac arrest occurring intra-hospital,
  • minor patient,
  • major patient under guardianship,
  • protected persons,
  • prior inclusion in the study

Trial locations and contacts

27 sites in 2 countries.

27 sites in 2 countries

France26 sites
  • CHU Amiens

    Amiens

  • CHU Angers

    Angers

  • CH Bethune

    Béthune

  • CHU Ambroise Paré

    Boulogne-Billancourt

  • CH Brive La Gaillard

    Brive-la-Gaillarde

  • CH Cherbourg en Cotentin

    Cherbourg

  • CHU Créteil

    Créteil

  • CHD Vendée

    La Roche-sur-Yon

  • CH La Rochelle

    La Rochelle

  • CH Versailles

    Le Chesnay

  • CH Le Mans

    Le Mans

  • CHU Lille

    Lille

  • Hospices Civils Lyon

    Lyon

  • APHM

    Marseille

  • Hopital Privé Jacques Cartier

    Massy

  • CHU Montpellier

    Montpellier

  • CHRU Nancy

    Nancy

  • CHU Nantes

    Nantes

  • APHP, CHU Necker

    Paris

  • APHP, CHU Saint Louis

    Paris

  • Aphp, Hegp

    Paris

  • CHU Cochin

    Paris

  • CHU Lariboisière

    Paris

  • GHP Saint Joseph

    Paris

  • Clinique Privé Claude Galien

    Quincy-sous-Sénart

  • CH Toulon

    Toulon

Other trials in France

Belgium1 site
  • ERASME

    Brussels

Other trials in Belgium

About this study

Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.

Conditions
Cardiac Arrest
Being tested
Calculation of early prognosis score
Keywords
cardiac arrest, hypothermia induced, intensive care unit
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Calculation of early prognosis scoreDiagnostic test

    Early prognosis score will be calculated at intensive care unit admission for each patient based on clinical and biological values as required

Study groups in NCT04167891
Study groupRoleWhat they receive
Patients admitted in the intensive care unitPatients with return of spontaneous circulation after cardiac arrest regardless of initial rhythm, and admitted in intensive care unit for post cardiac arrest care
Receives: Diagnostic Test: Calculation of early prognosis score

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determination of Area Under Curve of Cerebral Admission Hospital Prognosis (CAHP) Score at intensive care unit admission

    Determination of AUC for CAHP score as compare to Utstein style criteria.

    CAHP score range from 0 to 300 with higher score indicates poorer prognosis

    Measured: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)

Secondary outcomes (8)
  1. Determination of Area Under Curve of modified CAHP Score at intensive care unit admission

    Determination of AUC for modified CAHP score as compare to Utstein style criteria

    mCAHP score range from 0 to 280 with higher score indicates poorer prognosis

    Measured: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)

  2. Determination of Area Under Curve of simplified CAHP Score at intensive care unit admission

    Determination of AUC for simplified CAHP score as compare to Utstein style criteria

    sCAHP score range from 0 to 150 with higher score indicates poorer prognosis

    Measured: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)

  3. Determination of Area Under Curve of OHCA Score at intensive care unit admission

    Determination of AUC for OHCA score as compare to Utstein style criteria

    OHCA score range from -30 to 60 with higher score indicates poorer prognosis

    Measured: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)

  4. Determination of Area Under Curve of CREST Score at intensive care unit admission

    Determination of AUC for CREST score as compare to Utstein style criteria

    CREST score range from 0 to 5 with higher score indicates poorer prognosis

    Measured: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)

  5. Determination of Area Under Curve of C-Graph Score at intensive care unit admission

    Determination of AUC for C-Graph score as compare to Utstein style criteria

    C-Graph score range from 0 to 5 with higher score indicates poorer prognosis

    Measured: Intensive Care Unit Admission

  6. Determination of Area Under Curve of TTM Score at intensive care unit admission

    Determination of AUC for TTM score as compare to Utstein style criteria

    TTM score range from -2 to 35 with higher score indicates poorer prognosis

    Measured: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)

  7. Determination of Area Under Curve of NULL-PLEASE Score at intensive care unit admission

    Determination of AUC for NULL-PLEASE score as compare to Utstein style criteria

    NULL-PLEASE score range from 0 to 14 with higher score indicates poorer prognosis

    Measured: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)

  8. Determination of calibration of each score

    Determination of calibration of: CAHP, sCAHP, mCAHP, OHCA, CREST, C-Graph, TTM and NULL-PLEASE score

    Measured: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2019
  2. Study start1 Aug 2020
  3. Primary completion30 Jun 2022
  4. Study completion1 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,144 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04167891
Sponsor's protocol ID
AfterROSC1
Acronym
AfterROSC1
Status last verified
Sep 2024
First submitted
13 Nov 2019
Last updated
26 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Renaudier M, Lascarrou JB, Chelly J, Lesieur O, Bourenne J, Jaubert P, Paul M, Muller G, Leprovost P, Klein T, Yansli M, Daubin C, Petit M, Pichon N, Cour M, Sboui G, Geri G, Cariou A, Bougouin W. Fluid balance and outcome in cardiac arrest patients admitted to intensive care unit. Crit Care. 2025 Apr 14;29(1):152. doi: 10.1186/s13054-025-05391-x.

    PubMed 40229890
  • Lascarrou JB, Bougouin W, Chelly J, Bourenne J, Daubin C, Lesieur O, Asfar P, Colin G, Paul M, Chudeau N, Muller G, Geri G, Jacquier S, Pichon N, Klein T, Sauneuf B, Klouche K, Cour M, Sejourne C, Annoni F, Raphalen JH, Galbois A, Bruel C, Mongardon N, Aissaoui N, Deye N, Maizel J, Dumas F, Legriel S, Cariou A; AfterROSC Network. Prospective comparison of prognostic scores for prediction of outcome after out-of-hospital cardiac arrest: results of the AfterROSC1 multicentric study. Ann Intensive Care. 2023 Oct 11;13(1):100. doi: 10.1186/s13613-023-01195-w.

    PubMed 37819544

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Arrest, run by AfterROSC at 27 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 27 sites in France, Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determination of Area Under Curve of Cerebral Admission Hospital Prognosis (CAHP) Score at intensive care unit admission (time frame: Intensive Care Unit Admission (Usually 3 hours after cardiac arrest)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04167891, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in